NO20082149L - Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for bruk - Google Patents
Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for brukInfo
- Publication number
- NO20082149L NO20082149L NO20082149A NO20082149A NO20082149L NO 20082149 L NO20082149 L NO 20082149L NO 20082149 A NO20082149 A NO 20082149A NO 20082149 A NO20082149 A NO 20082149A NO 20082149 L NO20082149 L NO 20082149L
- Authority
- NO
- Norway
- Prior art keywords
- seq
- methods
- virus
- related compositions
- animal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241000282465 Canis Species 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000252869 H3N8 subtype Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Den foreliggende oppfinnelse tilveiebringer et isolert hundeinfluensavirus av undertype H3N8 som omfatter et HA som SEQ ID NO: 4 eller en aminosyresekvens som er mer enn 99% identisk til SEQ ID NO: 4, med det forbehold at aminosyrene ved posisjon 94 og 233 er identisk til SEQ ID NO: 4; en sammensetning som omfatter svekket eller inaktivert virus; isolert eller renset HA, NM, NP, Ml, NSI, PA, PB I og PB2 proteiner og fragmenter av dem og sammensetninger som omfatter det samme eller nukleinsyre, valgfritt som del av en vektor, som koder for det samme; og en fremgangsmåte for å indusere en immunrespons mot hundeinfluensavirus i et dyr som omfatter å gi til dyret en tidligere nevnt sammensetning.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72780805P | 2005-10-18 | 2005-10-18 | |
US11/539,123 US7468187B2 (en) | 2005-10-18 | 2006-10-05 | Canine influenza virus and related compositions and methods of use |
PCT/US2006/060025 WO2007048086A2 (en) | 2005-10-18 | 2006-10-17 | Canine influenza virus and related compositions and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20082149L true NO20082149L (no) | 2008-07-16 |
NO342145B1 NO342145B1 (no) | 2018-04-03 |
Family
ID=37906978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082149A NO342145B1 (no) | 2005-10-18 | 2008-05-07 | Hundeinfluensavirus, sammensetninger og anvendelse. |
Country Status (15)
Country | Link |
---|---|
US (4) | US7468187B2 (no) |
EP (1) | EP1933866B1 (no) |
JP (1) | JP5042230B2 (no) |
KR (1) | KR101412897B1 (no) |
AR (1) | AR056133A1 (no) |
AT (1) | ATE491468T1 (no) |
AU (1) | AU2006304895B2 (no) |
CA (1) | CA2626452C (no) |
DE (1) | DE602006018970D1 (no) |
HK (1) | HK1112846A1 (no) |
NO (1) | NO342145B1 (no) |
NZ (1) | NZ567017A (no) |
RS (1) | RS53723B1 (no) |
RU (1) | RU2410427C2 (no) |
WO (1) | WO2007048086A2 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
WO2006116082A1 (en) * | 2005-04-21 | 2006-11-02 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
ME00485B (me) * | 2005-10-07 | 2011-10-10 | Zoetis Services Llc | VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA |
AU2013205112C1 (en) * | 2005-10-19 | 2015-12-03 | Cornell Research Foundation, Inc. | Influenza viruses able to infect canids, uses thereof |
WO2007047728A2 (en) * | 2005-10-20 | 2007-04-26 | Wyeth | Compositions and methods for the treatment of canine influenza virus disease |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
ES2744126T3 (es) | 2006-10-25 | 2020-02-21 | Intervet Int Bv | Vacuna contra la gripe felina y método de uso |
CA2826058C (en) | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
PL2670432T3 (pl) | 2011-02-04 | 2021-10-11 | Zoetis Services Llc | Kompozycje immunogenne Bordetella bronchiseptica |
BR122019023542B1 (pt) | 2011-03-14 | 2022-02-15 | Boehringer Ingelheim Vetmedica, Inc | Composição imunogênica compreendendo uma ou mais cepas de vírus da rinite equina b (erbv) inativado e seu método de preparação |
KR101484588B1 (ko) * | 2012-10-24 | 2015-01-20 | 대한민국 | 개 인플루엔자 vlp 백신의 제조방법 |
US10080792B2 (en) | 2013-09-23 | 2018-09-25 | Engen Bio, Inc. | Influenza vaccine and therapy |
CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
BR112021000435A2 (pt) * | 2018-07-10 | 2021-04-06 | Seqirus Pty Ltd | Remoção de aglomerados |
JP7340290B2 (ja) * | 2021-05-21 | 2023-09-07 | 大輔 島岡 | 抗エンベロープウイルス中性洗浄剤、消毒剤組成物、及びエンベロープウイルスの不活性化方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4009258A (en) | 1972-09-25 | 1977-02-22 | The Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same |
GB1488800A (en) | 1973-11-29 | 1977-10-12 | Wellcome Found | Influenza vaccines |
US4140762A (en) | 1974-01-14 | 1979-02-20 | Sandoz Ltd. | Influenza sub-unit vaccine |
US4029763A (en) | 1974-08-05 | 1977-06-14 | Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
US4318903A (en) | 1978-07-12 | 1982-03-09 | Smithkline-Rit | Live influenza virus vaccine and the preparation thereof |
US4338296A (en) | 1979-10-16 | 1982-07-06 | Smithkline-Rit | Influenza virus and process of producing a vaccine therefrom |
US4278662A (en) | 1979-10-16 | 1981-07-14 | Smith Kline - Rit | Attenuated influenza type A virus vaccine |
GB8300467D0 (en) | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
JPH0688911B2 (ja) | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
GB8703696D0 (en) | 1987-02-18 | 1987-03-25 | Oxford J S | Influenza vaccine |
US5136019A (en) | 1989-05-24 | 1992-08-04 | Sri International | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
US5741493A (en) | 1991-01-24 | 1998-04-21 | Pasteur Merieux Serums Et Vaccins | Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive |
EP0590055B1 (en) | 1991-06-19 | 1997-12-03 | New York Medical College | M-protein peptides of influenza virus as antiviral agents |
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
ES2370937T3 (es) | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
BR9506484A (pt) | 1994-01-11 | 1997-10-07 | Vlaams Interuniv Inst Biotech | Neuraminidase recombinate seu vetor processo para sua manufatura e uso como vacina contra influenza |
US6482414B1 (en) | 1998-08-13 | 2002-11-19 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6177082B1 (en) | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
IL127331A0 (en) | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
WO2006116082A1 (en) | 2005-04-21 | 2006-11-02 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7384642B2 (en) * | 2005-08-25 | 2008-06-10 | Merial Limited | Canine influenza vaccines |
ME00485B (me) * | 2005-10-07 | 2011-10-10 | Zoetis Services Llc | VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA |
-
2006
- 2006-10-05 US US11/539,123 patent/US7468187B2/en active Active
- 2006-10-17 RU RU2008119438/10A patent/RU2410427C2/ru active
- 2006-10-17 EP EP06827896A patent/EP1933866B1/en active Active
- 2006-10-17 AT AT06827896T patent/ATE491468T1/de not_active IP Right Cessation
- 2006-10-17 CA CA2626452A patent/CA2626452C/en active Active
- 2006-10-17 JP JP2008536626A patent/JP5042230B2/ja active Active
- 2006-10-17 RS RS20080174A patent/RS53723B1/en unknown
- 2006-10-17 AU AU2006304895A patent/AU2006304895B2/en active Active
- 2006-10-17 WO PCT/US2006/060025 patent/WO2007048086A2/en active Application Filing
- 2006-10-17 NZ NZ567017A patent/NZ567017A/en unknown
- 2006-10-17 KR KR1020087008658A patent/KR101412897B1/ko active IP Right Grant
- 2006-10-17 DE DE602006018970T patent/DE602006018970D1/de active Active
- 2006-10-17 AR ARP060104532A patent/AR056133A1/es not_active Application Discontinuation
-
2008
- 2008-05-07 NO NO20082149A patent/NO342145B1/no unknown
- 2008-07-17 HK HK08107923.9A patent/HK1112846A1/xx unknown
- 2008-09-15 US US12/210,837 patent/US7842295B2/en not_active Ceased
-
2012
- 2012-11-29 US US13/688,990 patent/USRE44916E1/en active Active
-
2013
- 2013-11-08 US US14/075,618 patent/USRE45564E1/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR101412897B1 (ko) | 2014-06-27 |
RS20080174A (en) | 2009-07-15 |
EP1933866B1 (en) | 2010-12-15 |
EP1933866A2 (en) | 2008-06-25 |
AU2006304895B2 (en) | 2013-04-11 |
RU2410427C2 (ru) | 2011-01-27 |
NO342145B1 (no) | 2018-04-03 |
US20070098742A1 (en) | 2007-05-03 |
RS53723B1 (en) | 2015-06-30 |
RU2008119438A (ru) | 2009-11-27 |
AR056133A1 (es) | 2007-09-19 |
DE602006018970D1 (de) | 2011-01-27 |
JP5042230B2 (ja) | 2012-10-03 |
HK1112846A1 (en) | 2008-09-19 |
US7468187B2 (en) | 2008-12-23 |
ATE491468T1 (de) | 2011-01-15 |
CA2626452A1 (en) | 2007-04-26 |
WO2007048086A3 (en) | 2007-10-04 |
WO2007048086A9 (en) | 2007-07-19 |
JP2009511080A (ja) | 2009-03-19 |
AU2006304895A1 (en) | 2007-04-26 |
USRE45564E1 (en) | 2015-06-16 |
US20090035325A1 (en) | 2009-02-05 |
CA2626452C (en) | 2018-09-04 |
NZ567017A (en) | 2010-12-24 |
KR20080046706A (ko) | 2008-05-27 |
BRPI0617407A2 (pt) | 2011-07-26 |
US7842295B2 (en) | 2010-11-30 |
USRE44916E1 (en) | 2014-05-27 |
WO2007048086A2 (en) | 2007-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082149L (no) | Hundeinfluensavirus og relaterte sammensetninger og fremgangsmater for bruk | |
TW200732476A (en) | Functional influenza virus like particles (VLPs) | |
JP2008500399A5 (no) | ||
JP2009511080A5 (no) | ||
AR069882A1 (es) | Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e | |
MX342639B (es) | Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica. | |
WO2007126810A3 (en) | High titer recombinant influenza viruses for vaccines | |
BR0312173A (pt) | Mólecula de cdna, molécula e sequência de cdna recombinante, vetor, processo de preparação de partìculas de vìrus do sarampo infeccioso, composição imunogênica, composição de vacina e vìrus mononegaviral recombinante | |
NO20072882L (no) | Defekte influensaviruspartikler. | |
MY163972A (en) | Attenuated recombinant newcastle disease virus and vaccine containing the same | |
CY1109036T1 (el) | Εμβολιο περιλαμβανον εναν εξασθενημενο ιο πανωλης | |
EP2078083A4 (en) | NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR | |
NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
WO2007118206A3 (en) | Canine influenza virus | |
JP2014507146A5 (no) | ||
EA201990717A1 (ru) | Новая вакцина против гриппа свиней | |
MX2022012251A (es) | Vacuna universal contra la influenza usando arnm modificado con nucleósidos. | |
US20230285537A1 (en) | Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same | |
AU2009283557B2 (en) | Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration | |
DK1425404T3 (da) | Vaccinia-MVA-E3L-mutanter og anvendelse deraf | |
MX2023000041A (es) | Composiciones y metodos para inducir una respuesta inmunitaria contra coronavirus. | |
NZ603854A (en) | West nile virus vaccine | |
WO2020152318A3 (en) | High growth influenza virus | |
UA96743C2 (ru) | Вирус гриппа собачьих, композиция, содержащая вирус гриппа собачьих, и способ применения указанного вируса | |
NO20083576L (no) | Peptider av regulatoriske eller hjelpeproteiner av HIV, samt sammensetninger og anvendelser derav |